AKYA Market Cap History
Below is a table of the AKYA market cap history going back to 4/16/2021:

Date AKYA Market Cap
4/16/2021929.71M
4/30/2021832.76M
7/30/2021644.33M
10/31/2021493.00M
2/28/2022415.23M
4/29/2022353.72M
7/29/2022533.52M

Also see: AKYA Shares Outstanding History
and AKYA YTD Return
AKYA Historical Market Cap:
-35.09% CAGR
AKYA Historical Market Cap: +-35.09% CAGR

Mouse over chart for data details
4/16/20214/30/20217/30/202110/31/20212/28/20224/29/20227/29/2022
Akoya Biosciences is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Spatial biology is an evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler™ and PhenoImager™ platforms, reagents, software and services, Co. provides solutions to perform tissue analysis and spatial phenotyping across the continuum from discovery through translational and clinical research. We show 7 historical shares outstanding datapoints in our AKYA shares outstanding history coverage, used to compute AKYA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AKYA market cap history over the course of time is important for investors interested in comparing AKYA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AKYA versus a peer is one thing; comparing AKYA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AKYA can fluctuate over the course of history. With this page we aim to empower investors researching AKYA by allowing them to research the AKYA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree AKYA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akoya Biosciences (AKYA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ALBO Market Cap History
ALC Market Cap History
ALDR Market Cap History
ALDX Market Cap History
ALEC Market Cap History
ALGN Market Cap History
ALGS Market Cap History
ALHC Market Cap History
ALIM Market Cap History
ALKS Market Cap History
More Healthcare companies »

 

AKYA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.